IM Cannabis Corp. (IMCC)
IMCCNASDAQ-CM Medicinal Chemicals and Botanical Products
$0.5890
-0.0230 (-3.76%) today
Regular session, Nov 11, 10:46 AM ET
- Market cap
- $970.4k
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $0.5800 to $0.6300
- 52-week range
- $0.5805 to $62.40
- Average volume
- 3.34m
- Previous close
- $0.6120
Financials
No quarterly figures from the source.
News
8 latest- IM Cannabis Prices $1.31 Million Direct Share Offering; Stock Down In Pre-Market RTTNews · Sep 23, 2026
- IM Cannabis To Acquire 51% Of Space Defense Innovations, Stock Surges In Pre-Market RTTNews · Sep 23, 2026
- Biotech Stocks In Focus - IMCC +245%, XRTX +12%, SILO, BFRI RTTNews · Sep 18, 2026
- IM Cannabis Prices US$225,000 Convertible Note Financing To Support Corporate Operations RTTNews · Sep 3, 2026
- IM Cannabis Announces 30:1 Share Consolidation To Support Nasdaq Compliance; Stock Down RTTNews · Aug 19, 2026
- IM Cannabis Looks To Expand Operations Into US After Trump's Executive Order RTTNews · Dec 30, 2025
- IM Cannabis Signs Term Sheet To Acquire 60% Stake In Quantum Bio Data Firm RTTNews · Oct 23, 2025
- IM Cannabis Corp. Faces Global Challenges and Awaits Regulatory ReformsTipRanks · Jan 6, 2025
The company
IM Cannabis Corp. (NASDAQ: IMCC) is an international company operating a medical cannabis platform serving patients in Israel. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms in Israel that enable the safe delivery and quality control of IMCC's products throughout the value chain.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- imcannabis.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.